Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes and COVID-19: Population Impact 18 Months Into the Pandemic
Edward W. Gregg, Marisa K. Sophiea, Misghina Weldegiorgis
Diabetes Care (2021) Vol. 44, Iss. 9, pp. 1916-1923
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 211
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Post-COVID syndrome, inflammation, and diabetes
Ali A. Rizvi, Amita Kathuria, Wael Al Mahmeed, et al.
Journal of Diabetes and its Complications (2022) Vol. 36, Iss. 11, pp. 108336-108336
Open Access | Times Cited: 54
Association Between Diabetes Severity and Risks of COVID-19 Infection and Outcomes
James S. Floyd, Rod Walker, Jennifer L. Kuntz, et al.
Journal of General Internal Medicine (2023) Vol. 38, Iss. 6, pp. 1484-1492
Open Access | Times Cited: 15
A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries
Zulfiqar A Bhutta, Rehana A Salam, Apoorva Gomber, et al.
The Lancet (2021) Vol. 398, Iss. 10313, pp. 1837-1850
Closed Access | Times Cited: 28
Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation
Marina V. Shestakova, O. K. Vikulova, A. R. Elfimova, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
Relationships Among Select Comorbidities, Duration of Mechanical Ventilation, Treatment Modalities, and Patient Survival in Patients with COVID-19 who Require Extracorporeal Membrane Oxygenation (ECMO)

International Journal of Nursing and Health Care Research (2025) Vol. 8, Iss. 1
Open Access
Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study
Schafer Boeder, Emily Kobayashi, Gautam Ramesh, et al.
Journal of Diabetes Science and Technology (2022) Vol. 17, Iss. 3, pp. 642-648
Open Access | Times Cited: 18
The relationship between frailty, nutritional status, co-morbidity, CT-body composition and systemic inflammation in patients with COVID-19
Josh McGovern, Yassir Al‐Azzawi, Olivia Kemp, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Racial and ethnic disparities in cardiometabolic disease and COVID-19 outcomes in White, Black/African American, and Latinx populations: Physiological underpinnings
Kanokwan Bunsawat, Gregory J. Grosicki, Soolim Jeong, et al.
Progress in Cardiovascular Diseases (2022) Vol. 71, pp. 11-19
Open Access | Times Cited: 16
Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States
Rachel Bender Ignacio, Adrienne E. Shapiro, Robin M. Nance, et al.
AIDS (2022) Vol. 36, Iss. 8, pp. 1095-1103
Open Access | Times Cited: 15
COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management
Shahid S Memon, Dalia Biswas
Cureus (2022)
Open Access | Times Cited: 15
Human Serum Metabolites as Potential Mediators from Type 2 Diabetes and Obesity to COVID-19 Severity and Susceptibility: Evidence from Mendelian Randomization Study
Chuiguo Huang, Mai Shi, Hongjiang Wu, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 598-598
Open Access | Times Cited: 10
Evaluation of an Integrated Intervention to Address Clinical Care and Social Needs Among Patients with Type 2 Diabetes
Sarah E. Roth, Benjamin Gronowski, Kyle Jones, et al.
Journal of General Internal Medicine (2023) Vol. 38, Iss. S1, pp. 38-44
Open Access | Times Cited: 6
Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care
Stefano Zucchini, Andrea Scozzarella, Giulio Maltoni
World Journal of Diabetes (2023) Vol. 14, Iss. 3, pp. 198-208
Open Access | Times Cited: 5
Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study
Alice Cheng, Ronald Goldenberg, Iris Krawchenko, et al.
Canadian Journal of Diabetes (2023) Vol. 47, Iss. 5, pp. 398-404
Open Access | Times Cited: 5
What is the impact of microvascular complications of diabetes on severe COVID-19?
Ruman Basra, Martin Whyte, Janaka Karalliedde, et al.
Microvascular Research (2021) Vol. 140, pp. 104310-104310
Open Access | Times Cited: 11
COVID-19 Case Management Outcomes Amongst Diabetes and Hypertensive Patients in the United Arab Emirates: A Prospective Study
Aysha Alkhemeiri, Shaikha Al Zaabi, Lakshmanan Jeyaseelan, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 23, pp. 15967-15967
Open Access | Times Cited: 8
Impact of COVID-19 on diabetes care: mixed methods study in an Indigenous area of Guatemala
Magdalena Guarchaj, Scott Tschida, Juanita Patricia Milian Chew, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e079130-e079130
Open Access | Times Cited: 1
Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes
Yu Wang, Ping Zhang, Xilin Zhou, et al.
Diabetes Care (2024) Vol. 47, Iss. 3, pp. 452-459
Open Access | Times Cited: 1
Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19
Chi Nguyen, Christopher L. Crowe, Effie Kuti, et al.
Journal of health economics and outcomes research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Multiplex analysis of post-Covid cardiorenal complications in patients with type 1 and type 2 diabetes mellitus according to the mobile diagnostic and treatment center (Diamobil)
Olga Konstantinovna Vikulova, Anna V. Zheleznyakova, Alexey A. Serkov, et al.
Problems of Endocrinology (2024) Vol. 70, Iss. 4, pp. 65-74
Open Access | Times Cited: 1
Diabetic ketoacidosis in youth with diabetes mellitus during the COVID-19 pandemic
Anna Cymbaluk, Xiaofan Huang, Charles G. Minard, et al.
Journal of Pediatric Endocrinology and Metabolism (2024) Vol. 37, Iss. 9, pp. 759-763
Open Access | Times Cited: 1
Changes in diabetes care and management practices during the COVID-19 pandemic
Kushagra Vashist, Jennifer K. Frediani, Mary Beth Weber, et al.
Journal of Public Health (2024)
Open Access | Times Cited: 1
At-admission HbA1c levels in hospitalized COVID-19 participants with and without known diabetes
Andrea Valle, J. Rodríguez, Félix Camiña, et al.
Clinica Chimica Acta (2022) Vol. 532, pp. 188-192
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top